Saniona AB: Saniona progresses its Kv7 epilepsy program into

PRESS RELEASE August 16, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that it has progressed its promising Kv7 epilepsy program into the Lead Optimization

Related Keywords

Copenhagen , Køavn , Denmark , Stockholm , Sweden , United Kingdom , Thomas Feldthus , Palle Christophersen , , Lead Optimization Phase , Nasdaq Stockholm Small , Saniona , Progresses , Epilepsy , Program , Head , Ptimization ,